Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2008

Apr 30, 2008

29777_dirs_2008-04-29_16be7d12-7bdb-4dc2-afbf-4d3ecc140bde.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-04-25

Reporting Person: REYNOLDS W ANN (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-04-25 Common shares without par value A 1917 Acquired 42394 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 1747 Indirect
Common shares without par value 745 Indirect

Footnotes

F1: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F2: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11.

F3: The reporting person disclaims beneficial ownership of all securities held by her husband.